GENFIT Share Price OTC Markets
Stocks
GNFTF
FR0004163111
Biotechnology & Medical Research
OTC Markets Traded|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.75 USD | -2.18% |
|
-.--% | +79.17% |
| 03/07 | Genfit soars on news of U.S. reimbursement for a product |  |
| 03/07 | Genfit's Liver Disease Blood Test Approved for US Medicare Reimbursement | MT |
| Market Cap | 69Cr 78Cr 64Cr 59Cr 110.79Cr 7.5TCr 112.95Cr 758.74Cr 297.58Cr 3.68TCr 294.27Cr 287.83Cr 13TCr | P/E 2026 * |
72.3x | P/E 2027 * | 91.2x |
|---|---|---|---|---|---|
| Enterprise Value | 64Cr 73Cr 59Cr 54Cr 102.55Cr 6.94TCr 104.55Cr 702.31Cr 275.45Cr 3.41TCr 272.38Cr 266.43Cr 12TCr | EV / Sales 2026 * |
6.35x | EV / Sales 2027 * | 5.01x |
| Free-Float |
86.88% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -2.18% | ||
| 1 month | +7.72% | ||
| 3 months | +3.07% | ||
| 6 months | +79.17% | ||
| Current year | +79.17% |
| 1 month | 10.75 |  | 11.1 |
| Current year | 7.26 | | 11.1 |
| 1 year | 3.28 | | 11.1 |
| 3 years | 2.95 | | 11.1 |
| 5 years | 2.95 | | 11.1 |
| 10 years | 0 | | 36.86 |
| Manager | Title | Age | Since |
|---|---|---|---|
Pascal Prigent
CEO | Chief Executive Officer | 58 | 16/09/2019 |
Thomas Baetz
DFI | Director of Finance/CFO | 52 | 22/04/2021 |
Pejvack Motlagh
CTO | Chief Tech/Sci/R&D Officer | - | 27/11/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 70 | 16/06/2017 | |
| Director/Board Member | 54 | 15/09/1999 | |
| Director/Board Member | 58 | 16/06/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.18% | -.--% | - | - | 79Cr | |
| +0.44% | +1.41% | +4.25% | +10.81% | 5.07TCr | |
| -2.96% | -4.26% | +374.04% | +585.60% | 3.97TCr | |
| +1.47% | +2.66% | +32.04% | -3.73% | 3.47TCr | |
| +1.65% | -1.83% | +20.49% | +53.31% | 3.32TCr | |
| -0.06% | -4.63% | +2.94% | +31.65% | 2.68TCr | |
| -2.75% | -1.66% | - | - | 1.68TCr | |
| -0.76% | -5.41% | +66.84% | +122.32% | 1.54TCr | |
| +0.78% | +1.16% | +15.53% | +17.32% | 1.38TCr | |
| -0.08% | -1.91% | +12.15% | -32.66% | 1.28TCr | |
| Average | -0.42% | -0.98% | +66.04% | +98.08% | 2.71TCr | |
| Weighted average by Cap. | -0.14% | -0.38% | +80.77% | +123.29% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 10Cr 11Cr 9.28Cr 8.54Cr 16Cr 1.09TCr 16Cr 110.61Cr 43Cr 536.93Cr 43Cr 42Cr 1.85TCr | 12Cr 14Cr 11Cr 11Cr 20Cr 1.35TCr 20Cr 136.93Cr 54Cr 664.74Cr 53Cr 52Cr 2.3TCr |
| Net income | 2.29Cr 2.61Cr 2.12Cr 1.95Cr 3.69Cr 249.65Cr 3.76Cr 25Cr 9.91Cr 122.6Cr 9.79Cr 9.58Cr 423.4Cr | 68L 77.53L 62.98L 57.95L 1.1Cr 74Cr 1.12Cr 7.51Cr 2.94Cr 36Cr 2.91Cr 2.85Cr 125.85Cr |
| Net Debt | -5.11Cr -5.83Cr -4.73Cr -4.36Cr -8.24Cr -557.81Cr -8.4Cr -56Cr -22Cr -273.93Cr -22Cr -21Cr -946.01Cr | -6.62Cr -7.54Cr -6.13Cr -5.64Cr -11Cr -722.11Cr -11Cr -73Cr -29Cr -354.61Cr -28Cr -28Cr -1.22TCr |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GNFT Stock
- GNFTF Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
